- Home
- OPT vs NNDM Comparison
OPT vs NNDM Comparison
Compare OPT & NNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPT
- NNDM
- Stock Information
- Founded
- OPT 1984
- NNDM 2012
- Country
- OPT Australia
- NNDM Israel
- Employees
- OPT N/A
- NNDM N/A
- Industry
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- NNDM Electrical Products
- Sector
- OPT Health Care
- NNDM Technology
- Exchange
- OPT Nasdaq
- NNDM Nasdaq
- Market Cap
- OPT 574.0M
- NNDM 563.4M
- IPO Year
- OPT 2020
- NNDM N/A
- Fundamental
- Price
- OPT $3.90
- NNDM $2.33
- Analyst Decision
- OPT Strong Buy
- NNDM
- Analyst Count
- OPT 1
- NNDM 0
- Target Price
- OPT $12.00
- NNDM N/A
- AVG Volume (30 Days)
- OPT 18.3K
- NNDM 2.4M
- Earning Date
- OPT 02-26-2025
- NNDM 11-20-2024
- Dividend Yield
- OPT N/A
- NNDM N/A
- EPS Growth
- OPT N/A
- NNDM N/A
- EPS
- OPT N/A
- NNDM N/A
- Revenue
- OPT $261,859.00
- NNDM $57,660,000.00
- Revenue This Year
- OPT N/A
- NNDM $26.79
- Revenue Next Year
- OPT $46,864.26
- NNDM N/A
- P/E Ratio
- OPT N/A
- NNDM N/A
- Revenue Growth
- OPT N/A
- NNDM 6.85
- 52 Week Low
- OPT $1.79
- NNDM $2.04
- 52 Week High
- OPT $5.45
- NNDM $3.01
- Technical
- Relative Strength Index (RSI)
- OPT 56.41
- NNDM 47.39
- Support Level
- OPT $3.59
- NNDM $2.18
- Resistance Level
- OPT $3.90
- NNDM $2.37
- Average True Range (ATR)
- OPT 0.24
- NNDM 0.13
- MACD
- OPT 0.02
- NNDM -0.03
- Stochastic Oscillator
- OPT 74.11
- NNDM 30.00
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
About NNDM Nano Dimension Ltd.
Nano Dimension Ltd is a provider of intelligent machines for the fabrication of Additively Manufactured Electronics (AME). High-fidelity active electronic and electromechanical subassemblies are integral enablers of autonomous intelligent drones, cars, satellites, smartphones, and in medical devices. The portfolio of the company includes Mechanical, Chemical, Applications, Industrial Design, and Artificial Learning areas. Nano Dimension machines serve cross-industry needs by depositing proprietary consumable conductive and dielectric materials simultaneously, while concurrently integrating in-situ capacitors, antennas, coils, transformers, and electromechanical components, to function at an unprecedented performance.